Menu
GeneBe

rs537024768

Variant summary

Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2

The NM_000535.7(PMS2):c.950A>G(p.Gln317Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Q317K) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 31)

Consequence

PMS2
NM_000535.7 missense

Scores

6
11
2

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:3

Conservation

PhyloP100: 7.67
Variant links:
Genes affected
PMS2 (HGNC:9122): (PMS1 homolog 2, mismatch repair system component) The protein encoded by this gene is a key component of the mismatch repair system that functions to correct DNA mismatches and small insertions and deletions that can occur during DNA replication and homologous recombination. This protein forms heterodimers with the gene product of the mutL homolog 1 (MLH1) gene to form the MutL-alpha heterodimer. The MutL-alpha heterodimer possesses an endonucleolytic activity that is activated following recognition of mismatches and insertion/deletion loops by the MutS-alpha and MutS-beta heterodimers, and is necessary for removal of the mismatched DNA. There is a DQHA(X)2E(X)4E motif found at the C-terminus of the protein encoded by this gene that forms part of the active site of the nuclease. Mutations in this gene have been associated with hereditary nonpolyposis colorectal cancer (HNPCC; also known as Lynch syndrome) and Turcot syndrome. [provided by RefSeq, Apr 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
PMS2NM_000535.7 linkuse as main transcriptc.950A>G p.Gln317Arg missense_variant 9/15 ENST00000265849.12

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
PMS2ENST00000265849.12 linkuse as main transcriptc.950A>G p.Gln317Arg missense_variant 9/151 NM_000535.7 P3P54278-1

Frequencies

GnomAD3 genomes
Cov.:
31
GnomAD4 exome
Cov.:
27
GnomAD4 genome
Cov.:
31
Bravo
AF:
0.00000756

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingGenetic Services Laboratory, University of ChicagoSep 23, 2021DNA sequence analysis of the PMS2 gene demonstrated a sequence change, c.950A>G, in exon 9 that results in an amino acid change, p.Gln317Arg. This sequence change has not been described in population databases including ExAC and gnomAD (dbSNP rs537024768). The p.Gln317Arg change affects a highly conserved amino acid residue located in a domain of the PMS2 protein that is known to be functional. The p.Gln317Arg substitution appears to be deleterious using several in-silico pathogenicity prediction tools (SIFT, PolyPhen2, Align GVGD, REVEL). This sequence change does not appear to have been previously described in individuals with PMS2-related disorders, however a truncating variant at this position has been reported in an individual with early-age onset colorectal cancer and whose tumor showed loss of PMS2 by immunohistochemistry (PMID: 186029220). Due to insufficient evidences and the lack of functional studies, the clinical significance of the p.Gln317Arg change remains unknown at this time. -
Hereditary nonpolyposis colorectal neoplasms Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingInvitaeAug 31, 2021This sequence change replaces glutamine with arginine at codon 317 of the PMS2 protein (p.Gln317Arg). The glutamine residue is highly conserved and there is a small physicochemical difference between glutamine and arginine. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals affected with PMS2-related conditions. ClinVar contains an entry for this variant (Variation ID: 577182). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Hereditary cancer-predisposing syndrome Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsSep 17, 2020The p.Q317R variant (also known as c.950A>G), located in coding exon 9 of the PMS2 gene, results from an A to G substitution at nucleotide position 950. The glutamine at codon 317 is replaced by arginine, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.59
BayesDel_addAF
Pathogenic
0.38
D
BayesDel_noAF
Pathogenic
0.31
Cadd
Pathogenic
27
Dann
Uncertain
1.0
DEOGEN2
Uncertain
0.45
T;.;.;.;.
Eigen
Uncertain
0.48
Eigen_PC
Uncertain
0.39
FATHMM_MKL
Pathogenic
1.0
D
LIST_S2
Uncertain
0.96
D;D;.;D;.
M_CAP
Benign
0.041
D
MetaRNN
Uncertain
0.74
D;D;D;D;D
MetaSVM
Uncertain
0.42
D
MutationAssessor
Uncertain
2.1
M;.;.;.;.
MutationTaster
Benign
1.0
D;D;D;D;D
PrimateAI
Uncertain
0.57
T
PROVEAN
Uncertain
-3.6
D;D;.;.;.
REVEL
Pathogenic
0.74
Sift
Pathogenic
0.0
D;D;.;.;.
Sift4G
Uncertain
0.0070
D;D;.;.;.
Polyphen
1.0
D;D;.;.;D
Vest4
0.84
MutPred
0.53
Gain of methylation at Q317 (P = 0.0484);.;.;.;.;
MVP
0.90
MPC
0.28
ClinPred
0.99
D
GERP RS
5.4
Varity_R
0.92
gMVP
0.69

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs537024768; hg19: chr7-6031642; API